Lannett Co. Inc. | Mutual Funds
Mutual Funds that own Lannett Co. Inc.
iShares Core S&P Small Cap ETF
1,670,947
4.3%
474
0.02%
09/06/2018
Vanguard Small Cap Index Fund
863,471
2.22%
12,473
0.01%
07/31/2018
Vanguard Total Stock Market Index Fund
861,662
2.22%
0
0%
07/31/2018
iShares Russell 2000 ETF
616,762
1.59%
-330
0.01%
09/06/2018
SEI Institutional Managed Trust-Tax Managed Small/Mid Cap Fund
588,034
1.51%
483,104
0.22%
08/31/2018
Vanguard Small Cap Value Index Fund
539,373
1.39%
6,508
0.01%
07/31/2018
Heartland Value Fund
500,000
1.29%
0
0.31%
12/31/2017
Government Pension Fund - Global (The)
440,419
1.12%
18,885
0%
12/31/2017
Vanguard Extended Market Index Fund
403,216
1.04%
0
0%
07/31/2018
PowerShares S&P Small Cap Health Care Portfolio
349,577
0.9%
22,231
0.15%
09/05/2018
| Address |
9000 State Road
Philadelphia Pennsylvania 19136
United States
|
|
Employees
|
- |
| Website |
http://www.lannett.com |
| Updated |
07/08/2019 |
| Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escltalopram oxalate; renitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA. |
